**8. Conclusions**

The incidence of hepatic adenoma has increased lately as a result of more frequent imaging investigations performed for reasons not necessarily related to the presence of this benign tumor. The classical profile of the patient with adenoma has changed as a result of the emergence of new risk factors. As a result of research into phenotype, genotype, and imaging and the correlations of these results with clinical data, it is advisable that the diagnosis of hepatic adenoma include the subgroup of classification, which indicates the appropriate management of the case. The means of fitting the liver adenoma into the four subgroups are primarily imagistic, of which MRI has an essential role. In the case of insufficient data for the correct and complete diagnosis of hepatic adenoma, tumor biopsy is needed percutaneously or after tumor resection. Management of hepatic adenoma may mean on the one hand careful monitoring to recognize one of the two worrisome complications—hemorrhage and malignancy—and on the other hand, the treatment of the tumor, which may be asymptomatic or symptomatic, uncomplicated or complicated. In the elective cases, surgical resection remains the gold standard with a clear tendency toward laparoscopic approach in specialized centers, but in emergency cases caused by adenoma rupture, interventional arteriography has gained a net advantage over surgery. For rare cases of recurrent or extremely bulky hepatic adenomas, for which surgery is not feasible, but also for cases of liver adenomatosis on certain criteria, liver transplantation from cadaveric or living donor has become a reality. Careful monitoring of post-treatment patients should be continued and adapted according to the therapeutic outcomes and histopathology of the hepatic adenoma.

**141**

*Challenging Issues in Hepatic Adenoma DOI: http://dx.doi.org/10.5772/intechopen.87993*

complete writing this chapter.

**Thanks**

**Author details**

Mirela Boroș

Romania

Bucharest, Romania

Mirela Patricia Sîrbu Boeți

3

Institute, Bucharest, Romania

Fundeni Clinical Institute, Bucharest, Romania

\*Address all correspondence to: patriciaboeti@gmail.com

provided the original work is properly cited.

1,2\*, Beatrice Tivadar2

We thank our mentor Prof. Dr. Irinel Popescu, MD, PhD, FACS, for giving us the possibility to use data and iconography of patients that he operated on, in order to

, Dana Tomescu1,6 and Vladislav Brașoveanu2,5

1 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania

3 Radiology Medical Imaging and Interventional Radiology Department,

4 Department of Anatomopathology, Fundeni Clinical Institute, Bucharest,

5 'Titu Maiorescu' University of Medicine and Pharmacy, Bucharest, Romania

6 Department of Anesthesiology and Intensive Care, Fundeni Clinical Institute,

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

2 Department of General Surgery and Liver Transplantation, Fundeni Clinical

, Ioana G. Lupescu1,3, Vlad Herlea4,5,

*Challenging Issues in Hepatic Adenoma DOI: http://dx.doi.org/10.5772/intechopen.87993*
